The Chemours Company
CC
$14.62
-$0.3625-2.42%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.93% | 0.44% | -1.27% | 0.94% | -5.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.93% | 0.44% | -1.27% | 0.94% | -5.42% |
| Cost of Revenue | 7.30% | 5.01% | -3.11% | 0.08% | 1.05% |
| Gross Profit | -9.74% | -16.90% | 7.06% | 4.76% | -24.88% |
| SG&A Expenses | 17.11% | -11.03% | 49.62% | -19.26% | -18.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.36% | 3.06% | 2.28% | -1.74% | -1.66% |
| Operating Income | -44.62% | -26.67% | -50.00% | 34.55% | -33.33% |
| Income Before Tax | -478.26% | -100.00% | 113.04% | -330.77% | 115.94% |
| Income Tax Expenses | 1,222.22% | -75.00% | 132.08% | -400.00% | 115.79% |
| Earnings from Continuing Operations | -733.33% | -107.41% | 50.00% | -325.00% | 115.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -735.00% | -107.41% | 55.56% | -325.00% | 115.96% |
| EBIT | -44.62% | -26.67% | -50.00% | 34.55% | -33.33% |
| EBITDA | -25.49% | -13.61% | -25.88% | 21.51% | -25.27% |
| EPS Basic | -731.47% | -107.37% | 55.83% | -323.54% | 115.92% |
| Normalized Basic EPS | -82.87% | -55.19% | -127.63% | 45.12% | -54.52% |
| EPS Diluted | -751.28% | -108.33% | 54.04% | -325.50% | 115.46% |
| Normalized Diluted EPS | -82.79% | -54.89% | -127.63% | 46.62% | -54.73% |
| Average Basic Shares Outstanding | 0.55% | 0.59% | 0.65% | 0.72% | 0.21% |
| Average Diluted Shares Outstanding | 0.08% | -0.09% | 0.65% | -0.32% | 0.69% |
| Dividend Per Share | -65.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -1.06% | -14.50% | -1.19% | -1.46% | 7.10% |